The Endpoints Dataset: A Quality Control Method for Review and Analysis of Critical Efficacy Endpoints Data
Journal of the Society for Clinical Data Management · 2024-01-09 · 4 (1)
DOI: 10.47912/jscdm.174 ↗Abstract
INTRODUCTION: Clinical trial research is increasingly utilizing risk-based quality management systems. The identification and management of critical data elements is a crucial component of these systems. A quality control method is required to meet the needs of risk-based quality management systems with respect to critical data elements.OBJECTIVE: A quality control method, the endpoints dataset, is described to ensure critical efficacy endpoints data are identified and managed to guarantee fitness for purpose and support good decision making.METHODS: The endpoints dataset consists of four components: demographics, disposition, endpoints, and analysis. The structure of the endpoints dataset and each component are described in detail. A hypothetical endpoints dataset based on a randomized oncology clinical trial is provided to illustrate the detailed description of the endpoints dataset (supplemental material). RESULTS: The endpoints dataset compiles all required data to review and analyze the primary and secondary objectives of a clinical trial. Efficacy endpoints data are derived from clinical trial and external data for review and to support analysis. Analysis data is derived to directly support biostatistical analysis. All data is formatted in one record per subject.CONCLUSIONS: The generation of the endpoints dataset requires clinical data management and biostatistical teams to understand and agree on critical efficacy endpoints and analysis. Biostatistical analysis of the primary and many secondary endpoints can be carried out using only the endpoints dataset. This quality control method can be used for any type of clinical trial. The endpoints dataset is compared to the Analysis Data Model(CDISC ADaM).
EUVIMED